Simulation and initial proof-of-concept validation of a glycaemic regulation algorithm in critical care

Control Engineering Practice

Volumn 16, Issue 3, 2008, Pages 271-285

  Geoffrey Chase, J ^a,b   Wong, Xing Wei ^a   Singh Levett, Ishan ^a   Hollingsworth, Laura J ^a   Hann, Christopher E ^a   Shaw, Geoffrey M ^b,c   Lotz, Thomas ^b,c   Lin, Jessica ^b,c  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Blood glucose; Critical care; Hyperglycaemia; ICU; Insulin; Retrospective studies

Indexed keywords

ALGORITHMS; BLOOD; COMPUTER SIMULATION; DATA PROCESSING; GLUCOSE; HEALTH CARE; INSULIN; NUTRITION;

BLOOD GLUCOSE; GLYCAEMIC CONTROL; HYPERGLYCAEMIA;

INTENSIVE CARE UNITS;

ALGORITHMS; BLOOD; COMPUTER SIMULATION; DATA PROCESSING; GLUCOSE; HEALTH CARE; INSULIN; INTENSIVE CARE UNITS; NUTRITION;

EID: 36749060738     PISSN: 09670661     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conengprac.2007.04.009     Document Type: Article

References (54)

1. ARKRAY. Glucocard™ test strip 2 data sheet (2001), Arkray Inc, Japan
2. Basu A., Basu R., Shah P., Vella A., Johnson C.M., Jensen M., et al. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding-Additional evidence for a defect in hepatic glucokinase activity. Diabetes 50 (2001) 1351-1362
3. Basu R., Basu A., Johnson C.M., Schwenk W.F., and Rizza R.A. Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. Diabetes 53 (2004) 2042-2050
4. Bergman R.N., Finegood D.T., and Ader M. Assessment of insulin sensitivity in vivo. Endocrine Reviews 6 (1985) 45-86
5. Bergman R.N., Ider Y.Z., Bowden C.R., and Cobelli C. Quantitative estimation of insulin sensitivity. American Journal of Physiology 236 (1979) E667-E677
6. Bergman R.N., Phillips L.S., and Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: Measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. Journal of Clinical Investigation 68 (1981) 1456-1467
7. Bistrian B.R. Hyperglycemia and infection: Which is the chicken and which is the egg?. Journal of Parenteral and Enteral Nutrition 25 (2001) 180-181
8. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview. Lancet 355 (2000) 773-778
9. Chase J.G., Shaw G.M., Lin J., Doran C.V., Hann C., Robertson M.B., et al. Adaptive bolus-based targeted glucose regulation of hyperglycaemia in critical care. Medical Engineering & Physics 27 (2005) 1-11
10. Chee F., Fernando T., and Van Heerden P.V. Closed-loop control of blood glucose levels in critically ill patients. Anaesthesia and Intensive Care 30 (2002) 295-307
11. Consoli A. Role of liver in pathophysiology of niddm. Diabetes Care 15 (1992) 430-441
12. Cummins A.J. Absorption of glucose and methionine from the human intestine. Influence of the glucose concentration in the blood and the intestinal lumen. Journal of Clinical Investigation 31 (1952) 928-937
13. Defronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology 237 (1979) E214-E223
14. Doran C., Chase J., Shaw G., Moorhead K., and Hudson N. Derivative weighted active insulin control algorithms and intensive care unit trials. Control Engineering Practice 13 (2005) 1129-1138
15. Doran, C.V. (2004). Modelling and control of hyperglycemia in critical care patients. Mechanical Engineering, University of Canterbury, Christchurch, New Zealand.
16. Doran C.V., Hudson N.H., Moorhead K.T., Chase J.G., Shaw G.M., and Hann C.E. Derivative weighted active insulin control modelling and clinical trials for ICU patients. Medical Engineering & Physics 26 (2004) 855-866
17. Ellemann K., Thorsteinsson B., Fugleberg S., Feldt-Rasmussen B., Andersen O.O., Gronbaek P., et al. Kinetics of insulin disappearance from plasma in cortisone-treated normal subjects. Clinical Endocrinology (Oxford) 26 (1987) 623-628
18. Firth R., Bell P., Marsh H., Hansel I., and Rizza R. Post-prandial hyperglycemia in patients with non-insulin dependent diabetes mellitus: Role of hepatic and extrahepatic tissues. Journal of Clinical Investigation 74 (1985) 1525-1532
19. Furler S.M., Kraegen E.W., Smallwood R.H., and Chisholm D.J. Blood glucose control by intermittent loop closure in the basal mode: Computer simulation studies with a diabetic model. Diabetes Care 8 (1985) 553-561
20. Hann C.E., Chase J.G., Lin J., Lotz T., Doran C.V., and Shaw G.M. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Computer Methods and Programs in Biomedicine 77 (2005) 259-270
21. Hovorka R., Canonico V., Chassin L.J., Haueter U., Massi-Benedetti M., Federici M.O., et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiological Measurement 25 (2004) 905-920
22. Hovorka R., Chassin L.J., Wilinska M.E., Canonico V., Akwi J.A., Federici M.O., et al. Closing the loop: The adicol experience. Diabetes Technology & Therapeutics 6 (2004) 307-318
23. Hovorka R., Shojaee-Moradie F., Carroll P.V., Chassin L.J., Gowrie I.J., Jackson N.C., et al. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. American Journal of Physiology and Endocrinology Metabolism 282 (2002) E992-E1007
24. Kiwanuka E., Barazzoni R., and Tessari P. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects. Diabetes Nutrition & Metabolism 14 (2001) 315-324
25. Krinsley J.S. Decreased mortality of critically ill patients with the use of an intensive glycemic management protocol. Critical Care Medicine 31 (2003) A19
26. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clinic Proceedings 79 (2004) 992-1000
27. Kuehn L., and Blundell T. Insulin and glucagons receptors. In: Schulster D., and Levitski A. (Eds). Cellular receptors for hormones and neurotransmitters (1980), Wiley, Chichester
28. Larsen, M. O., Rolin, B., Wilken, M., Carr, R. D., & Svendsen, O. (2002). High-fat high-energy feeding impairs fasting glucose and increases fasting insulin levels in the Gottingen minipig-Results from a pilot study. Lipids and Insulin Resistance: The Role of Fatty Acid Metabolism and Fuel Partitioning.
29. Lehmann E.D., and Deutsch T. A physiological model of glucose-insulin interaction in type 1 diabetes mellitus. Journal of Biomedical Engineering 14 (1992) 235-242
30. Lonergan T., Lecompte A., Willacy M., Chase J.G., Shaw G.M., Wong X.W., et al. A simple insulin-nutrition protocol for tight glycemic control in critical illness: Development and protocol comparison. Diabetes Technology & Therapeutics 8 (2006) 191-206
31. Ludvik B., Nolan J.J., Roberts A., Baloga J., Joyce M., Bell J.M., et al. A noninvasive method to measure splanchnic glucose-uptake after oral glucose-administration. Journal of Clinical Investigation 95 (1995) 2232-2238
32. Ludvik B., Nolan J.J., Roberts A., Baloga J., Joyce M., Bell J.M., et al. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 100 (1997) 2354-2361
33. Mari A., Stojanovska L., Proietto J., and Thorburn A.W. A circulatory model for calculating non-steady-state glucose fluxes. Validation and comparison with compartmental models. Computer Methods and Programs in Biomedicine 71 (2003) 269-281
34. McCowen K.C., Malhotra A., and Bistrian B.R. Stress-induced hyperglycemia. Critical Care Clinic 17 (2001) 107-124
35. Mizock B.A. Alterations in fuel metabolism in critical illness: Hyperglycaemia. Best Practical Research in Clinical Endocrinology Metabolism 15 (2001) 533-551
36. Natali A., Gastaldelli A., Camastra S., Sironi A.M., Toschi E., Masoni A., et al. Dose-response characteristics of insulin action on glucose metabolism: A non-steady-state approach. American Journal of Physiology Endocrinology and Metabolism 278 (2000) E794-E801
37. Nielsen M.F., Basu R., Wise S., Caumo A., Cobelli C., and Rizza R.A. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: Evidence for a concentration-dependent defect in uptake. Diabetes 47 (1998) 1735-1747
38. Novartis. RESOURCE® diabetic nutrition information (2005), Novartis Medical Nutrition, USA
39. Patino J.F., de Pimiento S.E., Vergara A., Savino P., Rodriguez M., and Escallon J. Hypocaloric support in the critically ill. World Journal of Surgery 23 (1999) 553-559
40. Pehling G., Tessari P., Gerich J.E., Haymond M.W., Service F.J., and Rizza R.A. Abnormal meal carbohydrate disposition in insulin-dependent diabetes-Relative contributions of endogenous glucose-production and initial splanchnic uptake and effect of intensive insulin therapy. Journal of Clinical Investigation 74 (1984) 985-991
41. Prigeon R.L., Roder M.E., Porte Jr. D., and Kahn S.E. The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. Journal of Clinical Investigation 97 (1996) 501-507
42. Radziuk J., McDonald T.J., Rubenstein D., and Dupre J. Initial splanchnic extraction of ingested glucose in normal man. Metabolism-Clinical and Experimental 27 (1978) 657-669
43. Rizza R.A., Mandarino L.J., and Gerich J.E. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. American Journal of Physiology 240 (1981) E630-E639
44. Rubinson L., Diette G.B., Song X., Brower R.G., and Krishnan J.A. Low caloric intake is associated with nosocomial bloodstream infections in patients in the medical intensive care unit. Critical Care Medicine 32 (2004) 350-357
45. Steele R. Influence of glucose loading and of injected insulin on hepatic glucose output. Annals of the New York Academy of Science 82 (1959) 420-430
46. Thorburn A., Litchfield A., Fabris S., and Proietto J. Abnormal transient rise in hepatic glucose-production after oral glucose in non-insulin-dependent diabetic subjects. Diabetes Research and Clinical Practice 28 (1995) 127-135
47. Thorsteinsson B., Fugleberg S., Feldt-Rasmussen B., Ellemann K., and Binder C. Kinetics models for insulin disappearance from plasma in type 1 diabetic patients. Pharmacology and Toxicology 60 (1987) 90-95
48. Transberg K., Hagander P., and Thorell J. Disappearance of insulin in man: Variation with the plasma insulin level. Acta Endocrinology (Copenhagen) 97 (1981) 391-397
49. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., et al. Intensive insulin therapy in the critically ill patients. New England Journal of Medicine 345 (2001) 1359-1367
50. Van den Berghe G., Wouters P.J., Bouillon R., Weekers F., Verwaest C., Schetz M., et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Critical Care Medicine 31 (2003) 359-366
51. Weissman C. Nutrition in the intensive care unit. Critical Care 3 (1999) R67-R75
52. Weitgasser R., Gappmayer B., and Pichler M. Newer portable glucose meters-Analytical improvement compared with previous generation devices?. Clinical Chemistry 45 (1999) 1821-1825
53. Wolfe R.R. Glucose metabolism. Radioactive and stable isotope tracers in biomedicine: Principles and practice of kinetic analysis (1992), Wiley-Liss, New York
54. Woolfson A.M. Control of blood glucose during nutritional support in ill patients. Intensive Care Medicine 7 (1980) 11-14